Grant: Strategic Projects - Group
University of Toronto
$168,700.00
An Ultrasensitive Microfluidic Biosensor Based on Vertically-Aligned MoS2 Nanolayers
EF 2018-19
Résumé
Next-generation biosensors that exploit highly-sensitive, two-dimensional (2D) nanomaterials could provide superior analytical performance and thus enable rapid, ultrasensitive tests for a variety of applications in areas such as molecular diagnosis, environmental monitoring, and food safety inspection. Atomically-thin monolayer molybdenum disulfide (MoS2), as an emerging graphene-like 2D nanomaterial, has attracted significant attention from the biosensor community. Despite the recent advancement in developing high-performance monolayer MoS2 biosensors, previously reported devices suffer from low fabrication yield, challenging biofunctionalization, and low reproducibility; these issues can be largely attributed to some inherent property and preparation process of monolayer MoS2 that are not favorable in biosensor development. In this project, we propose, for the first time, to integrate a novel form of MoS2 nanostructure, vertically-aligned MoS2 nanolayers (VAMNs), into microfluidic field-effect-transistor (FET) biosensors. Because of its unique nanostructures, the VAMNs enable a few new features that do not exist in previous MoS2 biosensors, including facile and reliable covalent immobilization of biomolecules on its vertically-aligned, populated active edge sites and good computability with batch microfabrication. In the meanwhile, the proposed FET-biosensor will also retain the advantageous physical properties of monolayer MoS2 such as its direct bandgap, ultrahigh sensitivity to surface molecule binding, and fast response; therefore, it could provide significantly-enhanced biosensing performance including ultrahigh sensitivity and high stability/reproducibility. The microfluidic design of our biosensor also allows easy device operation, multiplexed assay, and low sample consumption. As the first demonstration, we will apply our FET-biosensor to rapid, ultrasensitive detection of brain injury protein markers for constant monitoring of patient brain conditions during cardiac surgery. This research will offer a powerful VAMN-based biosensing platform, which could find many important applications where ultrahigh sensitivity and very short array time are desired.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
494012-2016
Name nom
Liu, Xinyu
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2016
Award amount
168700
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1586
Committee name en
Strategic Projects - Advanced Manufacturing
Committee name fr
Projets stratégiques - Fabrication de pointe
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
3
Nb partie
3
Application title
An Ultrasensitive Microfluidic Biosensor Based on Vertically-Aligned MoS2 Nanolayers
Keyword
NSERC
Application summary
Next-generation biosensors that exploit highly-sensitive, two-dimensional (2D) nanomaterials could provide superior analytical performance and thus enable rapid, ultrasensitive tests for a variety of applications in areas such as molecular diagnosis, environmental monitoring, and food safety inspection. Atomically-thin monolayer molybdenum disulfide (MoS2), as an emerging graphene-like 2D nanomaterial, has attracted significant attention from the biosensor community. Despite the recent advancement in developing high-performance monolayer MoS2 biosensors, previously reported devices suffer from low fabrication yield, challenging biofunctionalization, and low reproducibility; these issues can be largely attributed to some inherent property and preparation process of monolayer MoS2 that are not favorable in biosensor development. In this project, we propose, for the first time, to integrate a novel form of MoS2 nanostructure, vertically-aligned MoS2 nanolayers (VAMNs), into microfluidic field-effect-transistor (FET) biosensors. Because of its unique nanostructures, the VAMNs enable a few new features that do not exist in previous MoS2 biosensors, including facile and reliable covalent immobilization of biomolecules on its vertically-aligned, populated active edge sites and good computability with batch microfabrication. In the meanwhile, the proposed FET-biosensor will also retain the advantageous physical properties of monolayer MoS2 such as its direct bandgap, ultrahigh sensitivity to surface molecule binding, and fast response; therefore, it could provide significantly-enhanced biosensing performance including ultrahigh sensitivity and high stability/reproducibility. The microfluidic design of our biosensor also allows easy device operation, multiplexed assay, and low sample consumption. As the first demonstration, we will apply our FET-biosensor to rapid, ultrasensitive detection of brain injury protein markers for constant monitoring of patient brain conditions during cardiac surgery. This research will offer a powerful VAMN-based biosensing platform, which could find many important applications where ultrahigh sensitivity and very short array time are desired.